SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: July 13, 1995
UNIGENE LABORATORIES, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
----------------------------------------------
(State or other jurisdiction of incorporation)
0-16005 22-2328609
- ------------------------ ------------------------------------
(Commission File Number) (IRS Employer Identification Number)
110 Little Falls Road
Fairfield, New Jersey 07004
---------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(201) 882-0860
----------------------------------------------------
(Registrant's telephone number, including area code)
Item 5. Other Events.
On July 13, 1995, the Company completed the extension of the
maturity of a $2,000,000 short-term debt financing to September 8, 1995.
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
10.20 Letter Agreement between the Company and The MicroCap
Fund, Inc. dated July 13, 1995.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.
UNIGENE LABORATORIES, INC.
By /s/ Warren P. Levy
-----------------------
Warren P. Levy, Ph.D.
President
Date: July 27, 1995